- Learn about rising drugs costs and the new discipline of interventional pharmacoeconomics (IVPE).
- See how the IVPE substitution strategy can be applied to LHRH therapy in prostate cancer to encourage a reduction in drug costs.
- Explore how the IVPE less frequent dosing strategy can be applied to nivolumab and pembrolizumab to reduce drug costs.
Monday, February 3, 2020 - 12:00pm to 1:00pm
Brian L. Heiss, MD
900 East 57th StreetKCBD Auditorium 1103
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation